Other languages Aceso Life Science Group Limited

Equities

474 KYG0070S1066

Delayed Hong Kong S.E. Other stock markets 04:07:42 09/05/2024 BST			5-day change	1st Jan Change
0.155 ^HKD	-0.64%		0.00%	+38.39%

02-23	Aceso Life Science Group Limited Announces Resignation of Xu Haiying as Executive Director	CI
2023	Aceso Life Science's Loss Widens in Fiscal H1	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aceso Life Science Group Limited Announces Resignation of Xu Haiying as Executive Director	02-23
Aceso Life Science's Loss Widens in Fiscal H1	11-29
Aceso Life Science Group Limited Reports Earnings Results for the Half Year Ended September 30, 2023	11-28
Aceso Life Science Group Limited Provides Group Earnings Guidance for the Six Months Ended 30 September 2023	11-20
Aceso Life Science Cuts Holdings in Hao Tian International Construction to 29%; Aceso Shares Drop 12%	18/10/23
Aceso Life Science Group Limited Reports Earnings Results for the Full Year Ended March 31, 2023	28/06/23
Hao Tian International Unit Buys HK$250 Million Bonds	14/06/23
Hao Tian International Construction Unit Signs Property License Deal	13/02/23
Aceso Life Science Narrows April-September Loss	30/11/22
Aceso Life Science Group Limited Reports Earnings Results for the Half Year Ended September 30, 2022	29/11/22
Aceso Life Science Group to Shrink April-Sept Loss	21/11/22
Aceso Life Science Group Limited Provides Group Earnings Guidance for the Six Months Ended 30 September 2022	21/11/22
Aceso Life Science Group Limited Announces Change of Company Secretary	26/08/22
Aceso Life Science Group Limited Reports Earnings Results for the Full Year Ended March 31, 2022	29/06/22
Aceso Life Science, Hao Tian International Unit to Purchase Bonds at $45.2 Million	23/06/22
Aceso Life Science Expects to Deepen Loss in FY22	13/06/22
Aceso Life Science Group Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 March 2022	10/06/22
Aceso Life Science Group Limited commences an Equity Buyback Plan for 738,681,681 shares, representing 10% of its issued share capital, under the authorization approved on September 17, 2021.	28/02/22
Aceso Life Science Group Limited Announces Changes in Composition of the Nomination Committee	29/12/21
Aceso Life Science Sees Fiscal H1 Attributable Loss Drop	29/11/21

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Aceso Life Science Group Limited

Equities

474

KYG0070S1066

Other languages

Filters